Shanghai MicroPort MedBot (Group) Co., Ltd.
Industry Group: Healthcare
Country/Region: China
Identifier: HKG:2252
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. Its business covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives key revenue from the People's Republic of China, followed by Europe, Africa, Australia, and other regions.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Healthcare 472 out of 563
Universe
Global Universe 11219 out of 14683
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the non-India based rated subjects, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Elekta AB |
17.4
Low
|
78 out of 563 |
QuidelOrtho Corp. |
24.7
Medium
|
262 out of 563 |
Veracyte, Inc. |
26.3
Medium
|
304 out of 563 |
SKAN Group AG |
28.4
Medium
|
355 out of 563 |
Shanghai MicroPort MedBot (Group) Co., Ltd. |
33
High
|
472 out of 563 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Shanghai MicroPort MedBot (Group) Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Shanghai MicroPort MedBot (Group) Co., Ltd.'s Management of ESG Material Risk is Average